RTW Investments, LP 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 08:09 am Sale |
2025-03-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW Investments, LP | 2,922,729 6.000% |
-1,128,636 (-27.86%) |
Filing |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW Investments, LP | 4,051,365 8.400% |
-438,231 (-9.76%) |
Filing |
| 2024-02-14 07:26 am Purchase |
2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW Investments, LP | 4,489,596 9.500% |
1,509,114 (+50.63%) |
Filing |
| 2023-02-14 10:07 am Purchase |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW Investments, LP | 2,980,482 6.900% |
2,980,482 (New Position) |
Filing |